Defining and Characterizing the Progression of Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is a progressive disease in which the risks of myocardial infarction, stroke, microvascular events, and mortality are all strongly associated with hyperglycemia (1). The disease course is primarily characterized by a decline in �-cell function and worsening of insulin resistance. The process is manifested clinically by deteriorations in multiple parameters, including A1C, fasting plasma glucose (FPG), and postprandial glucose levels. In this review, we will evaluate our current understanding of the role played by deteriorating �-cell function and other abnormalities linked with the progression of type 2 diabetes. An improved understanding of these abnormalities may provide the scientific groundwork for novel therapies that may help achieve and maintain good glycemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Moreover, the essential oil extracted from CW, primarily comprising esters (58.3%) and ketones (33.5%), has also demonstrated notable free radical scavenging activity and antioxidant potential [49].”
From Research Progress in Coconut Water: A Review of Nutritional Composition, Biological Activities, and Novel Processing Technologies (2025) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Regardless of the treatment regime, longitudinal studies in humans have demonstrated that beta-cell function generally deteriorates over time.49,50”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Following the induction of insulin resistance, islet beta-cells can maintain normoglycaemia and metabolic homeostasis by increasing their secretion of insulin and/or by increasing their number.49,96,97”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“The gradual decline in islet beta-cell number and function results in insulin levels becoming too low to promote metabolic homeostasis and T2D results.49,91”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Obesity has been estimated to induce an ~50% increase in islet beta-cell volume due to increased neogenesis.49”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.
Polonsky, K. S., Given, B. D., & Van Cauter, E. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113339 · Cited by 763
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 583
Pick, A., Clark, J., Kubstrup, C., Levisetti, M., Pugh, W., Bonner-Weir, S., & Polonsky, K. S. (1998) · Diabetes · doi:10.2337/diabetes.47.3.358 · Cited by 551
Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.
Kahn, S. E., Andrikopoulos, S., & Verchere, C. B. (1999) · Diabetes · doi:10.2337/diabetes.48.2.241 · Cited by 488
Mechanisms of β-Cell Death in Type 2 Diabetes
Donath, M. Y., Ehses, J. A., Maedler, K., Schumann, D. M., Ellingsgaard, H., Eppler, E., & Reinecke, M. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s108 · Cited by 444
Pancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes
Tushuizen, M. E., Bunck, M. C., Pouwels, P. J., Bontemps, S., van Waesberghe, J. H. T., Schindhelm, R. K., Mari, A., Heine, R. J., & Diamant, M. (2007) · Diabetes Care · doi:10.2337/dc07-0326 · Cited by 400
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15318 · Cited by 363
Weyer, C., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.89 · Cited by 357
Structural and Functional Abnormalities in the Islets Isolated From Type 2 Diabetic Subjects
Deng, S., Vatamaniuk, M., Huang, X., Doliba, N., Lian, M.-M., Frank, A., Velidedeoglu, E., Desai, N. M., Koeberlein, B., Wolf, B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.3.624 · Cited by 349
Meigs, J. B., Muller, D. C., Nathan, D. M., Blake, D. R., & Andres, R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1475 · Cited by 338
Islet Inflammation in Type 2 Diabetes
Donath, M. Y., Schumann, D. M., Faulenbach, M., Ellingsgaard, H., Perren, A., & Ehses, J. A. (2008) · Diabetes Care · doi:10.2337/dc08-s243 · Cited by 334
Frayling, T. M., Evans, J. C., Bulman, M. P., Pearson, E., Allen, L., Owen, K., Bingham, C., Hannemann, M., Shepherd, M., Ellard, S., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s94 · Cited by 276
Progression From Newly Acquired Impaired Fasting Glusose to Type 2 Diabetes
Nichols, G. A., Hillier, T. A., & Brown, J. B. (2007) · Diabetes Care · doi:10.2337/dc06-1392 · Cited by 272
Alpha cell function in health and disease: influence of glucagon-like peptide-1
Dunning, B. E., Foley, J. E., & Ahrén, B. (2005) · Diabetologia · doi:10.1007/s00125-005-1878-0 · Cited by 271
The Natural Course of β-Cell Function in Nondiabetic and Diabetic Individuals
Festa, A., Williams, K., D’Agostino, R., Wagenknecht, L. E., & Haffner, S. M. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1100 · Cited by 271
Cytokines and β-Cell Biology: from Concept to Clinical Translation
Donath, M. Y., Størling, J., Berchtold, L. A., Billestrup, N., & Mandrup-Poulsen, T. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0033 · Cited by 222
The ORIGIN Trial Investigators (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.09.009 · Cited by 204
Relationship Between β-Cell Mass and Fasting Blood Glucose Concentration in Humans
Ritzel, R. A., Butler, A. E., Rizza, R. A., Veldhuis, J. D., & Butler, P. C. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-1538 · Cited by 197
Cnop, M., Vidal, J., Hull, R. L., Utzschneider, K. M., Carr, D. B., Schraw, T., Scherer, P. E., Boyko, E. J., Fujimoto, W. Y., & Kahn, S. E. (2007) · Diabetes Care · doi:10.2337/dc06-1834 · Cited by 174
Different genes, different diabetes: lessons from maturity-onset diabetes of the young
Stride, A., & Hattersley, A. T. (2002) · Annals of Medicine · doi:10.1080/713782136 · Cited by 164
Mode of onset of type 2 diabetes from normal or impaired glucose tolerance
Ferrannini, E., Nannipieri, M., Williams, K., Gonzales, C., Haffner, S. M., & Stern, M. P. (2004) · Diabetes · doi:10.2337/diabetes.53.1.160 · Cited by 153
Pancreatic volume in type 1 und type 2 diabetes mellitus
Goda, K., Sasaki, E., Nagata, K., Fukai, M., Ohsawa, N., & Hahafusa, T. (2001) · Acta Diabetologica · doi:10.1007/s005920170012 · Cited by 118
Mechanisms of Impaired Fasting Glucose and Glucose Intolerance Induced by a ∼50% Pancreatectomy
Matveyenko, A. V., Veldhuis, J. D., & Butler, P. C. (2006) · Diabetes · doi:10.2337/db06-0345 · Cited by 83
Size of pancreas in diabetes mellitus: a study based on ultrasound.
Fonseca, V. A., Berger, L. A., Beckett, A. G., & Dandona, P. (1985) · BMJ · doi:10.1136/bmj.291.6504.1240 · Cited by 71
Self-citationPani, L., Nathan, D. M., & Grant, R. W. (2008) · Diabetes Care · doi:10.2337/dc07-1934 · Cited by 71
Long-Term Normoglycemic Remission in Black Newly Diagnosed NIDDM Subjects
Banerji, M. A., Chaiken, R. L., & Lebovitz, H. E. (1996) · Diabetes · doi:10.2337/diab.45.3.337 · Cited by 67
Kumar, A. F., Gruessner, R. W. G., & Seaquist, E. R. (2008) · Diabetes Care · doi:10.2337/dc07-2453 · Cited by 62
Coefficient of failure: a methodology for examining longitudinal β‐cell function in Type 2 diabetes
Wallace, T. M., & Matthews, D. R. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00718.x · Cited by 51
UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years
UK Prospective Diabetes Study (UKPDS) Group, Matthews, D. R., Cull, C. A., Stratton, I. M., Holman, R. R., & Turner, R. C. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199804)15:4
Cited by
Human temperature regulation under heat stress in health, disease, and injury
Cramer, M. N., Gagnon, D., Laitano, O., & Crandall, C. G. (2022) · Physiological Reviews · doi:10.1152/physrev.00047.2021 · Cited by 491
Lim, J., Kim, J., Koo, S. H., & Kwon, G. C. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212963 · Cited by 464
Environmental Risk Factors for Developing Type 2 Diabetes Mellitus: A Systematic Review
Dendup, T., Feng, X., Clingan, S., & Astell-Burt, T. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010078 · Cited by 440
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Li, X., Dunn, J., Salins, D., Zhou, G., Zhou, W., Schüssler-Fiorenza Rose, S. M., Perelman, D., Colbert, E., Runge, R., Rego, S., et al. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2001402 · Cited by 431
Metadata
- Authors
- Fonseca, V. A.
- Affiliations
- Tulane University (US)
- Corresponding author
- Fonseca, Vivian A.
- ORCID
- Fonseca, Vivian A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S151-S156
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811457
- OpenAlex
- W2128050336
- Cited by
- 573
- References
- 40
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 50 · 2023: 51 · 2022: 41 · 2021: 51 · 2020: 54 · 2019: 50 · 2018: 43 · 2017: 37 · 2016: 43 · 2015: 37 · 2014: 23 · 2013: 17 · 2012: 7
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes progression, beta-cell function decline, insulin resistance, hyperglycemia, glycemic control, HbA1c, fasting blood glucose, postprandial blood glucose, microvascular complications, cardiovascular risk
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Insulin Resistance, Obesity, Prediabetic State, Weight Gain, Disease Progression, Postprandial Period, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.